Collaborative Effort Unveils Promising Breakthrough in Psoriasis Treatment: Advanced Fusion Protein Enzymes Target Chronic Inflammation with Reduced Side Effects

[Initially published June 9, 2023]

Dr. Benjamin Keselowsky (PI), Dr. Gregory Hudalla (Co-I), and their collaborators have received a $3.8M grant from the NIH National Institute of Allergy and Infectious Diseases. The grant aims to address the problem of psoriasis, a chronic auto-inflammatory disease that causes irreversible damage to the skin.